| Registrars: | Capita Registrars |
| CEO: | Christina Coughlin |
| Non-Executive Chairman: | Richard Hughes |
| Senior Independent Director: | Patrick Vink |
| Non-Executive Dir: | Mark Goldberg, David Bryant, Mats Blom |
| Address: | Scale Space, White City, Imperial College Campus, 58 Wood Lane, London, United Kingdom, LS23 7FA |
| Phone: | +44 (0)20 3911 0353 |
| Fax: | +44 (0)84 4414 0453 |
| Website: | http://avacta.com/ |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| Domestic Listings: | LSE:E3X1770 |
| ISIN: | GB00BYYW9G87 |
| Currency | UK Pounds |
| Share Price | 72.00p |
| Closing Price Change | 4.00p |
| % Change | 0.00 % |
| 52 Week High | 89.50p |
| 52 Week Low | 49.50p |
| Volume | 0 |
| Shares Issued | 471.33m |
| Market Cap | £339.36m |
| Beta | 0.01 |
| RiskGrade | 461 |
| Value | ![]() |
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 1 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |

| No dividends found |
You are here: research